Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Allogene Therapeutics Inc (ALLO)

Allogene Therapeutics Inc (ALLO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Allogene Therapeutics: Q1 Earnings Snapshot AP - Mon May 13, 3:17PM CDT

Allogene Therapeutics: Q1 Earnings Snapshot

ALLO : 2.12 (+1.92%)
Allogene Therapeutics: Q4 Earnings Snapshot AP - Thu Mar 14, 3:15PM CDT

Allogene Therapeutics: Q4 Earnings Snapshot

ALLO : 2.12 (+1.92%)
Allogene Therapeutics: Q3 Earnings Snapshot AP - Thu Nov 2, 2023

Allogene Therapeutics: Q3 Earnings Snapshot

ALLO : 2.12 (+1.92%)
A Bull Market Is Coming: 1 Beaten-Down Growth Stock You Could Regret Not Buying on the Dip Motley Fool - Tue Oct 10, 2023

Wall Street price targets suggest this stock can rocket more than 400% higher.

CRBU : 1.5950 (-0.31%)
ALLO : 2.12 (+1.92%)
GILD : 66.71 (+0.18%)
Cantor Fitzgerald Bolsters Healthcare and Biotechnology Equity Research Team with Addition of Josh Schimmer, M.D., and Eric Schmidt, Ph.D. PR Newswire - Tue Sep 5, 2023

/PRNewswire/ -- Cantor Fitzgerald, L.P., ("Cantor") a leading global financial services firm, today announced the addition of Josh Schimmer, M.D., and Eric...

ALLO : 2.12 (+1.92%)
Allogene Therapeutics: Q2 Earnings Snapshot AP - Wed Aug 2, 2023

Allogene Therapeutics: Q2 Earnings Snapshot

ALLO : 2.12 (+1.92%)
Author
3 Stocks With Sky-High Short Interest Levels MarketBeat - Mon Jul 31, 2023

BYND, BTAI, and ALLO stand out as high short-interest stocks to watch due to their potential for price fluctuations and short-squeeze opportunities.

BTAI : 1.0750 (-0.46%)
BYND : 7.09 (+3.81%)
ALLO : 2.12 (+1.92%)
CVNA : 128.07 (+0.18%)
RIVN : 14.82 (+1.16%)
ENVX : 16.02 (+4.84%)
Allogene Therapeutics: Q1 Earnings Snapshot AP - Wed May 3, 2023

Allogene Therapeutics: Q1 Earnings Snapshot

ALLO : 2.12 (+1.92%)
Allogene Therapeutics: Q4 Earnings Snapshot AP - Tue Feb 28, 2023

Allogene Therapeutics: Q4 Earnings Snapshot

ALLO : 2.12 (+1.92%)
Short Squeezes Have Returned in 2023 -- Here's Your Playbook Motley Fool - Wed Feb 8, 2023

We haven't seen moves like these in a couple of years, so here's what investors should know.

GME : 24.15 (-0.90%)
CVNA : 128.07 (+0.18%)
SI : 1.2500 (+0.81%)
BBBY : 0.0751 (-27.09%)
ALLO : 2.12 (+1.92%)
MARA : 20.18 (-3.81%)
WMT : 69.94 (+2.49%)

Barchart Exclusives

3 Standout Stocks to Buy for Q3 2024 Barchart - 48 minutes ago
As we enter the third quarter of 2024, here are three promising stocks investors could consider buying. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot